Literature DB >> 6345328

Experimental studies on pancreatic duct occlusion with prolamine.

C Gebhardt, M Stolte, P O Schwille, H Zirngibl, W Engelhardt.   

Abstract

The effect of the occlusion of the pancreatic duct system with prolamine (Ethibloc) has been studied in animal experiments with dogs and mini-pigs. The solution becomes solid in the duct system and becomes disintegrated again within 11 days. This time, however, is sufficient to keep a high-grade atrophy of the exocrine parenchyma. With this method one doesn't risk the provocation of an acute pancreatitis. The endocrine function of the atrophied glands is satisfactory, no animal became diabetic. The basal jugular vein insulin shows no difference to that of the control group, but nevertheless the mean whole pancreas hormone content is reduced for insulin and somatostatin, but not for glucagon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345328

Source DB:  PubMed          Journal:  Horm Metab Res Suppl        ISSN: 0170-5903


  3 in total

1.  Application of air insufflation to prevent clinical pancreatic fistula after pancreaticoduodenectomy.

Authors:  Hui Yang; Xiao-Fei Lu; Yun-Fei Xu; Hong-Da Liu; Sen Guo; Yi Liu; Yu-Xin Chen
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

2.  Occlusion of the pancreatic duct versus pancreaticojejunostomy: a prospective randomized trial.

Authors:  Khe Tran; Casper Van Eijck; Valerio Di Carlo; Wim C J Hop; Alessandro Zerbi; Gianpaolo Balzano; Hans Jeekel
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

3.  Biliary and pancreatic secretions influence experimental duodenal ulcer without affecting gastric secretion in the rat.

Authors:  G Pihan; G T Gallagher; S Szabo
Journal:  Dig Dis Sci       Date:  1985-03       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.